Steven Cohen's DFTX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 483,980 shares of Definium Therapeutics, Inc. (DFTX) worth $22.77 M, representing 0.03% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in DFTX, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 308,490 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Definium Therapeutics (DFTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Definium Therapeutics (DFTX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +308,490 | Add 175.79% | 483,980 | $47.04 |
| Q1 2026 | +175,490 | New Buy | 175,490 | $18.90 |
Steven Cohen's Definium Therapeutics Investment FAQs
Steven Cohen first purchased Definium Therapeutics, Inc. (DFTX) in Q1 2026, acquiring 175,490 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Definium Therapeutics, Inc. (DFTX) for 2 quarters since Q1 2026.
Steven Cohen's largest addition to Definium Therapeutics, Inc. (DFTX) was in Q2 2026, adding 483,980 shares worth $22.77 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 483,980 shares of Definium Therapeutics, Inc. (DFTX), valued at approximately $22.77 M.
As of the Q2 2026 filing, Definium Therapeutics, Inc. (DFTX) represents approximately 0.03% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Definium Therapeutics, Inc. (DFTX) was 483,980 shares, as reported at the end of Q2 2026.